These aforementioned potential ADCs’ candidates mesotheline, DLL3, folate receptor alpha, guanylatcyclase, glycoprotein NMB, CD56 and CD70 whose targets are expressed in other cancer entities could not be considered for further protein expression analysis due to missing gene expression. This evidence concerns the gene DLL3 and cancer.